FLSM
IMTX icon

Frazier Life Sciences Management’s Immatics IMTX Stock Holding History

Frazier Life Sciences Management’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,247,911
Closed -$5.63M – 51
2025
Q1 		$5.63M Sell
1,247,911
-900,000
-42% -$4.7M 0.26% 40
2024
Q4 		$15.3M Buy
2,147,911
+793,200
+59% +$6.82M 0.63% 31
2024
Q3 		$15.5M Buy
1,354,711
+202,255
+18% +$2.39M 0.62% 34
2024
Q2 		$13.4M Buy
+1,152,456
New +$13M 0.63% 32

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Frazier Life Sciences Management's IMTX Position: Q2 2025 in Review

Frazier Life Sciences Management sold out of Immatics (IMTX) in Q2 2025, closing a stake of 1,247,911 shares — an estimated $5.63M sold.

Frazier Life Sciences Management first reported a position in IMTX in Q2 2024 and held it in 4 quarters. The position peaked at $15.5M in Q3 2024. 70 funds tracked by Wall St. Rank hold IMTX as of Q2 2025.

  • Frazier Life Sciences Management reported no remaining Immatics position as of Q2 2025 after selling out during the quarter.
  • Frazier Life Sciences Management sold 1,247,911 Immatics shares in Q2 2025, an estimated $5.63M.
  • Frazier Life Sciences Management first reported a position in Immatics in Q2 2024 and held it in 4 quarters.
  • Frazier Life Sciences Management's Immatics position peaked at $15.5M in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Immatics as of Q2 2025.

Based on Frazier Life Sciences Management's 13F filing for Q2 2025, filed 14 Aug 2025.